Kiffik Biomedical

Kiffik Biomedical is an early-stage diagnostics company pioneering a novel platform for continuous, non-invasive biomarker monitoring from interstitial fluid (ISF). Its core technology, KIFFIK EXP, is a wearable device that captures molecular data not readily available in blood, targeting applications in clinical trial optimization, companion diagnostics, and remote patient monitoring. The company is currently in the investigational stage, partnering with pharmaceutical and diagnostic leaders to validate its platform across multiple therapeutic areas, including oncology, women's health, and military medicine.

KIFFIK EXP platform: a non-invasive wearable device for continuous, real-time collection and analysis of molecular biomarkers from interstitial fluid (ISF), paired with data informatics (KIFFIK Lab).

Competition includes other companies developing continuous biomarker monitors (e.g., for sweat or other biofluids) and established central lab/diagnostics firms. Kiffik's unique focus on ISF and its tissue-proximal biomarker profile is its key differentiator, but it must prove this translates to clinical advantage.